Safety and Efficacy of Tripalmitoleoylglycerol in the Treatment of Dermatitis | MicrobiomeTrials← Back to trialsNCT07366255
Safety and Efficacy of Tripalmitoleoylglycerol in the Treatment of Dermatitis
CompletedNAINTERVENTIONAL
Trial Details
Start: 2026-01-10Est. Completion: 2026-03-05
Enrollment target: 46 participants Locations- Department of Dermatology, Shenzhen People's Hospital, Shenzhen, Guangdong, China
Other microbiome trials you might be interested in
Incontinence-Associated Dermatitis, Dermatitis, Skin Barrier Dysfunction
Incontinence-associated dermatitis (IAD) is a common skin condition among long-term care residents and is caused by prol…
Longtan, TaiwanCompleted Nov 30, 2023
Seborrheic Dermatitis on the Face
This is a 4-week comparison study between the intervention and control sides of the face. Purposive sampling to recruit …
Ratchathewi, ThailandEst. completion Jun 30, 2026